Cargando…
Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems
The clinical practice of selective serotonin reuptake inhibitor (SSRI) augmentation relies heavily on trial-and-error. Unfortunately, the drug combinations prescribed today fail to provide relief for many depressed patients. In order to identify potentially more effective treatments, we developed a...
Autores principales: | Camacho, Mariam B., Vijitbenjaronk, Warut D., Anastasio, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823241/ https://www.ncbi.nlm.nih.gov/pubmed/31708770 http://dx.doi.org/10.3389/fphar.2019.01215 |
Ejemplares similares
-
Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
por: Camacho, Mariam B., et al.
Publicado: (2017) -
Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
por: García-Gutiérrez, María Salud, et al.
Publicado: (2023) -
Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
por: Hache, Guillaume, et al.
Publicado: (2011) -
Brain regions and monoaminergic neurotransmitters that are involved in mouse ambulatory activity promoted by bupropion
por: Umezu, Toyoshi, et al.
Publicado: (2016) -
Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
por: Morgese, Maria Grazia, et al.
Publicado: (2019)